Structure

InChI Key IOMMMLWIABWRKL-WUTDNEBXSA-N
Smiles Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1
InChI
InChI=1S/C26H31ClN6O2/c1-18-16-19(12-13-28-18)25(35)30-26-29-22-10-6-9-21(27)24(22)33(26)20-8-4-5-15-32(17-20)23(34)11-7-14-31(2)3/h6-7,9-13,16,20H,4-5,8,14-15,17H2,1-3H3,(H,29,30,35)/b11-7+/t20-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C26H31ClN6O2
Molecular Weight 495.03
AlogP 4.32
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 6.0
Polar Surface Area 83.36
Molecular species BASE
Aromatic Rings 3.0
Heavy Atoms 35.0

Pharmacology

Mechanism of Action Action Reference
Epidermal growth factor receptor erbB1 inhibitor INHIBITOR Other ClinicalTrials DOI
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Kinase Protein Kinase TK protein kinase group Tyrosine protein kinase EGFR family
- 4.18-160.6 - - -
EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Homo sapiens
- 1.52-160.6 - - -

Target Conservation

Protein: Epidermal growth factor receptor erbB1

Description: Epidermal growth factor receptor

Organism : Homo sapiens

P00533 ENSG00000146648

Cross References

Resources Reference
ChEMBL CHEMBL3787344
DrugBank DB16250
FDA SRS KE7K32EME8
Guide to Pharmacology 9204
PubChem 72703790
SureChEMBL SCHEMBL16767232
ZINC ZINC000210610738